Painchek Ltd
Research Painchek Ltd (PCK) on Bullrun: market cap AUD 18.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPCK
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyAUD
- Market capAUD 18.00M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 18.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.04 | n/a | n/a | n/a |
| FY2024 | AUD 2.67M | -AUD 8.31M | -AUD 7.16M | 27.0% | -0.06 | AUD 3.56M | n/a | AUD 1.29M |
| FY2023 | AUD 1.95M | -AUD 7.57M | -AUD 6.34M | 36.5% | -0.06 | AUD 2.51M | n/a | AUD 668.13K |
| FY2022 | AUD 978.57K | -AUD 5.72M | -AUD 7.02M | -26.4% | -0.05 | AUD 6.14M | n/a | AUD 4.82M |
| FY2021 | AUD 214.80K | -AUD 6.06M | -AUD 4.18M | -197.5% | n/a | AUD 11.42M | n/a | AUD 8.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-13 | AUD 18.00M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Painchek Ltd
PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Painchek Ltd's market cap?
Painchek Ltd's market capitalization is AUD 18.00M.
What does Painchek Ltd do?
PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018.